These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19836257)

  • 21. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery.
    Margaritora S; Cesario A; Cusumano G; Cafarotti S; Corbo GM; Ferri L; Ceppi M; Meacci E; Valente S; D'Angelillo RM; Russo P; Porziella V; Bonassi S; Pasqua F; Sterzi S; Granone P
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1457-63. PubMed ID: 20363001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A; Alifano M; Bobbio A; Grigoroiu M; Jouni R; Magdeleinat P; Regnard JF
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary resection after high-dose and low-dose chest irradiation.
    Cerfolio RJ; Bryant AS; Spencer SA; Bartolucci AA
    Ann Thorac Surg; 2005 Oct; 80(4):1224-30; discussion 1230. PubMed ID: 16181844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications: DLCO/VA% is More important than predicted postoperative %DLCO?
    Takeda S
    Ann Thorac Surg; 2010 May; 89(5):1706-7; author reply 1707. PubMed ID: 20417833
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
    Daly BD; Fernando HC; Ketchedjian A; Dipetrillo TA; Kachnic LA; Morelli DM; Shemin RJ
    Ann Thorac Surg; 2006 Jul; 82(1):227-31. PubMed ID: 16798219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study.
    Shennib H; Bogart J; Herndon JE; Kohman L; Keenan R; Green M; Sugarbaker D; ;
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):813-8. PubMed ID: 15821648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomical lung resection after neoadjuvant chemoradiotherapy.
    Burrows WM
    Semin Thorac Cardiovasc Surg; 2007; 19(4):360-5. PubMed ID: 18395639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemotherapy as a predisposing factor for colonization of upper respiratory tract with Candida spp. in patients with non-small cell lung cancer.
    Furmanik F; Rybojad P; Kasprzycka A; Korona-Głowniak I; Malm A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):42-6. PubMed ID: 15323164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.
    Krasna MJ; Gamliel Z; Burrows WM; Sonett JR; Kwong KF; Edelman MJ; Hausner PF; Doyle LA; DeYoung C; Suntharalingam M
    Ann Thorac Surg; 2010 Jan; 89(1):200-6; discussion 206. PubMed ID: 20103235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant chemoradiotherapy and peroperative radiotherapy for non-small-cell lung cancer of the apex. A study of 5 cases].
    Vincent L; Guibert B; Mornex F; Grangeon V; Harf R; Gormand F; Pacheco Y
    Rev Pneumol Clin; 2001 Sep; 57(4):271-7. PubMed ID: 11593153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of induction therapy on morbidity and operative mortality after resection of primary lung cancer.
    Evans NR; Li S; Wright CD; Allen MS; Gaissert HA
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):991-6.e1-2. PubMed ID: 20304144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer.
    Ross P; Grecula J; Bekaii-Saab T; Villalona-Calero M; Otterson G; Magro C
    Lasers Surg Med; 2006 Dec; 38(10):881-9. PubMed ID: 17115382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer.
    Petersen RP; Pham D; Toloza EM; Burfeind WR; Harpole DH; Hanish SI; D'Amico TA
    Ann Thorac Surg; 2006 Jul; 82(1):214-8; discussion 219. PubMed ID: 16798217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.